Blue Trust Inc. Trims Stake in UnitedHealth Group Incorporated $UNH

Blue Trust Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 13.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,936 shares of the healthcare conglomerate’s stock after selling 1,277 shares during the quarter. Blue Trust Inc.’s holdings in UnitedHealth Group were worth $2,476,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Thompson Investment Management Inc. raised its holdings in shares of UnitedHealth Group by 100.5% in the 2nd quarter. Thompson Investment Management Inc. now owns 33,205 shares of the healthcare conglomerate’s stock valued at $10,359,000 after buying an additional 16,644 shares during the period. NavPoint Financial Inc. raised its holdings in shares of UnitedHealth Group by 6.4% in the 2nd quarter. NavPoint Financial Inc. now owns 1,293 shares of the healthcare conglomerate’s stock valued at $404,000 after buying an additional 78 shares during the period. Galvin Gaustad & Stein LLC increased its holdings in UnitedHealth Group by 35.5% during the 2nd quarter. Galvin Gaustad & Stein LLC now owns 78,913 shares of the healthcare conglomerate’s stock worth $24,618,000 after purchasing an additional 20,688 shares during the period. Cardano Risk Management B.V. increased its holdings in UnitedHealth Group by 2.4% during the 2nd quarter. Cardano Risk Management B.V. now owns 263,367 shares of the healthcare conglomerate’s stock worth $82,163,000 after purchasing an additional 6,169 shares during the period. Finally, Elefante Mark B increased its holdings in UnitedHealth Group by 9.2% during the 2nd quarter. Elefante Mark B now owns 6,441 shares of the healthcare conglomerate’s stock worth $2,009,000 after purchasing an additional 541 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several recent research reports. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday. Sanford C. Bernstein increased their price objective on UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a report on Wednesday. Mizuho increased their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday. Truist Financial increased their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Finally, Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Trading Down 3.6%

Shares of UNH stock opened at $354.30 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The business’s 50 day moving average is $318.21 and its two-hundred day moving average is $350.41. The company has a market capitalization of $320.88 billion, a P/E ratio of 15.35, a price-to-earnings-growth ratio of 2.38 and a beta of 0.47. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.